Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03911687 · ClinicalTrials.gov registry record · NA

(CONCERN) Clinical Decision Support (CDS) System

A NA study of Hospital Acquired Condition, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
60,893
Enrollment target
4
Study locations

NCT03911687 is a NA study of Hospital Acquired Condition that has completed, run by Columbia University. The registered enrollment target is 60,893 participants, above the 765-participant average among 5 other Hospital Acquired Condition trials with a reported enrollment target (7860% higher). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03911687, a NA study of Hospital Acquired Condition, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
60,893 participants
Enrollment target
4
Study locations

Study Summary

There are patients who die or have a bad outcome in the hospital and this could be prevented. Data in the nurses' notes could be used by computers to tell the rest of the care team that a patient is not doing well and that they should act more quickly. This project will build and evaluate a computer system that makes it easier for the care team to see and understand that data and act quickly to save patients. The aims of this study is to answer the questions, what is the level of provider use of the CONCERN CDS notification system (called CONCERN SMARTapp) and resulting impact on selected patient outcomes? Specifically, the study has 1) validated desired thresholds for the CONCERN CDS system and 2) integrated the CONCERN CDS system for early warning of risky patient states within CDS tools. In this portion of the study (aim 3), the investigator will implement and evaluate the CONCERN CDS system on primary outcomes of in-hospital mortality and length of stay and secondary outcomes of cardiac arrest, unanticipated transfers to the intensive care unit, and 30-day hospital readmission rates.

Interventions

  • BEHAVIORAL CONCERN CDS system notification

Study Locations (4)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Newton-Wellesley Hospital - Newton

New York

  • New York Presbyterian Columbia University Medical Center - New York
  • New York Presbyterian Allen Hospital - New York

Trial Details

FieldValue
Enrollment Target 60,893 participants
Start Date 2020-07-21
Est. Completion 2022-10-31
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03911687

The ClinicalTrials.gov registry entry for NCT03911687 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60,893 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 765-participant average among 5 other Hospital Acquired Condition trials with a reported enrollment target (7860% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hospital Acquired Condition appearing as the primary indexed condition, and to 1 intervention - of which CONCERN CDS system notification is the first listed.

NCT03911687 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT03911687 about?

NCT03911687 is a clinical study titled "(CONCERN) Clinical Decision Support (CDS) System". There are patients who die or have a bad outcome in the hospital and this could be prevented. Data in the nurses' notes could be used by computers to tell the rest of the care team that a patient is not doing well and that they should act more quickly. This project will build and evaluate a computer...

What is the current status of trial NCT03911687?

This trial is currently completed. It is a NA study. The enrollment target is 60,893 participants. The study started on 2020-07-21. Estimated completion is 2022-10-31.

What conditions does trial NCT03911687 study?

This clinical trial studies the following conditions: Hospital Acquired Condition.

What interventions are being tested in trial NCT03911687?

The interventions under investigation include: CONCERN CDS system notification (BEHAVIORAL).

Who is sponsoring clinical trial NCT03911687?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03911687 being conducted?

This trial has 4 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hospital Acquired Condition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.